Welcome to LookChem.com Sign In|Join Free
  • or
Cyclohexanecarboxylic acid, 1-[(2-benzofuranylcarbonyl)amino]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

652170-08-6

Post Buying Request

652170-08-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

652170-08-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 652170-08-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,2,1,7 and 0 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 652170-08:
(8*6)+(7*5)+(6*2)+(5*1)+(4*7)+(3*0)+(2*0)+(1*8)=136
136 % 10 = 6
So 652170-08-6 is a valid CAS Registry Number.

652170-08-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(1-benzofuran-2-carbonylamino)cyclohexane-1-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-[(2-benzofuranylcarbonyl)amino]cyclohexanecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:652170-08-6 SDS

652170-08-6Relevant academic research and scientific papers

Cycloalkylcarbonylamino Acid Derivative and Process For Producing The Same

-

Page/Page column 19, (2009/05/28)

Cycloalkylcarbonylamino acid derivatives, which are raw material intermediates of a novel cycloalkane carboxamide derivative that selectively inhibits cathepsin K, and a production process thereof, are provided. A cycloalkylcarbonylamino acid derivative r

Cycloalkylcarbonylamino Acid Ester Derivative and Process for Producing The Same

-

Page/Page column 19, (2009/06/27)

Cycloalkylcarbonylamino acid ester derivatives, which are raw material intermediates for a novel cycloalkane carboxamide derivative having an action that selectively inhibits cathepsin K, and a production process thereof, are provided. A cycloalkylcarbony

CYCLOALKANECARBOXAMIDE DERIVATIVE AND METHOD FOR PRODUCING SAME

-

Page/Page column 26, (2008/12/08)

Novel cycloalkane carboxamide derivatives having an action that selectively inhibits cathepsin K, and a production process thereof, are provided. A cycloalkane carboxamide derivative represented by the following general formula (I), or a pharmaceutically acceptable salt thereof: (wherein R1 and R2 represent (substituted) alkyl groups, (substituted) alkenyl groups, (substituted) alkynyl groups, (substituted) aromatic hydrocarbon groups or (substituted) heterocyclic groups, ring A represents an alkylidene group having 5 to 7 carbon atoms, and ring B represents a formyl group or a hydroxymethyl group).

OXAZOLONE DERIVATIVE

-

Page/Page column 23-24, (2008/12/07)

Novel raw material compounds are provided that are useful for producing novel cycloalkane carboxamide derivatives having cathepsin K inhibitory action. An oxazolone derivative represented by formula (I): [wherein, R1 represents a substituted or unsubstituted alkyl group, substituted or unsubstituted alkenyl group, substituted or unsubstituted alkynyl group, substituted phenyl group, substituted or unsubstituted naphthyl group or substituted or unsubstituted heterocyclic group, and ring A represents a saturated cyclic alkylidene group having 6 to 7 carbon atoms].

1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF

-

Page 23-24, (2010/02/06)

The present invention provides 1-phenylpiperidin-3-one derivatives and pharmaceutically acceptable saltsthereof, having cysteine protease inhibitory activity, pharmaceutical compositions containing the sameas an active ingredient, and processes for the preparation thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 652170-08-6